Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
77.82M | 97.56M | 101.39M | 76.89M | 104.60M | 99.83M | Gross Profit |
12.22M | 21.00M | 14.85M | 2.98M | -15.81M | -4.86M | EBIT |
-20.47M | -14.73M | -12.32M | -11.41M | -30.38M | -23.01M | EBITDA |
-18.25M | -712.00K | -15.12M | -7.32M | -22.66M | -1.46M | Net Income Common Stockholders |
-12.96M | -7.48M | -19.04M | -10.42M | -29.45M | -7.21M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.46M | 1.23M | 20.57M | 2.21M | 1.19M | 14.56M | Total Assets |
21.62M | 23.37M | 105.72M | 64.19M | 24.11M | 61.18M | Total Debt |
34.54M | 35.54M | 41.93M | 39.12M | 37.77M | 28.82M | Net Debt |
31.52M | 34.31M | 21.36M | 36.91M | 36.58M | 14.25M | Total Liabilities |
52.38M | 54.52M | 163.21M | 116.03M | 68.25M | 75.86M | Stockholders Equity |
-30.76M | -31.15M | -57.49M | -51.84M | -44.14M | -14.69M |
Cash Flow | Free Cash Flow | ||||
-18.29M | -21.75M | -17.10M | -26.31M | -16.25M | -10.85M | Operating Cash Flow |
-18.31M | -21.45M | -11.23M | -26.31M | -16.23M | -3.38M | Investing Cash Flow |
89.00K | -299.00K | -5.47M | 5.57M | 2.52M | 10.36M | Financing Cash Flow |
18.07M | 1.66M | 35.66M | 21.75M | 343.00K | -2.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
66 Neutral | $4.47B | 12.22 | 5.40% | 3.65% | 4.14% | -12.00% | |
62 Neutral | HK$149.58M | 2.85 | 17.83% | ― | 6.62% | 72.58% | |
51 Neutral | HK$149.93M | ― | -18.22% | ― | -56.16% | 62.50% | |
47 Neutral | HK$19.85M | ― | -2.91% | ― | 10.22% | 92.89% | |
35 Underperform | HK$360.28M | ― | ― | -23.18% | -117.81% | ||
35 Underperform | HK$186.86M | ― | ― | -37.75% | -11.19% | ||
$44.80M | ― | ― | ― | ― |